A critical shortage of powdered infant formula revealed significant challenges in the supply, market competition and regulation of formula in the United States.
A team led by Dr. Samie Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a three-year, $1.65 million grant for RNA research under a biotechnology-development program run by the U.S. National Science Foundation.
A study led by researchers at Weill Cornell Medicine and the New York Genome Center found that antiviral enzymes that mutate the DNA of normal and cancer cells are key promoters of early bladder cancer development.
A new study helps explain how moving cells respond to environmental cues and set up internal structures that enable them to keep going in one direction during organ development, wound healing, cancer metastasis and many other processes
A clinical trial led by Weill Cornell Medicine investigators showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heart rhythms.
Feuerstein has founded several digital health companies and is the executive director and founder of Yale School of Medicine’s Center for Digital Health and Innovation.
ACT for Youth, which promotes adolescent health and well-being in New York state, has been awarded $5 million to help local health departments improve care for youth with special needs.
The 2024 CROPPS Annual Meeting and Symposium held in October in the Sonoran Desert region of Arizona provided an ideal stage for discussions on sustainable agriculture in hot, dry environments.
A study identifies microbes that potentially play important roles in breaking down harmful PFAS chemicals and points to functional genes that may be involved.